insights_auto
Why is 0QF up 5,04%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
183,86 €
arrow_upward
+5,04%(+8,82) 1D
9 қаз., 15:41:34 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
175,40 €
High
185,00 €
Low
174,18 €
Mkt. cap
82,88 млрд
Avg. vol.
28,88 мың
Volume
16,74 мың
52-wk high
188,30 €
52-wk low
19,37 €
No. of employees
5 мың
Open
175,40 €
High
185,00 €
Low
174,18 €
Mkt. cap
82,88 млрд
Avg. vol.
28,88 мың
Volume
16,74 мың
52-wk high
188,30 €
52-wk low
19,37 €
No. of employees
5 мың
News stories
From web sources and news partners
AD HOC NEWS
·
16 минут бұрын
Nasdaq adds Moderna to the Nasdaq-100. Moderna stock gains 2.51 percent
Simply Wall Street
·
2 сағат бұрын
Learn Why The Bull Case For Moderna Stock Could Change Following COO Appointment
MarketBeat
·
7 сағат бұрын
Rep. Maria Elvira Salazar Unloads Shares of Moderna, Inc. (NASDAQ:MRNA)
Yahoo Finance
·
1 күн бұрын
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc